{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:17:17Z","timestamp":1791274637246,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001786","name":"University of Adelaide","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001786","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.ijcard.2020.11.044","type":"journal-article","created":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T02:02:25Z","timestamp":1606096945000},"page":"130-140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Risk and predictors of sudden death in cardiac sarcoidosis: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"328","author":[{"given":"Kyle B.","family":"Franke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Kennewell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huy-Dat","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip J.","family":"Tully","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thirakan","family":"Rattanakosit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gnanadevan","family":"Mahadevan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9923","key":"10.1016\/j.ijcard.2020.11.044_bb0005","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(13)60680-7","volume":"383","author":"Valeyre","year":"2014","journal-title":"Sarcoidosis. Lancet."},{"key":"10.1016\/j.ijcard.2020.11.044_bb0010","first-page":"89","article-title":"Diagnostic standard and guidelines for sarcoidosis","volume":"27","author":"Hiraga","year":"2007","journal-title":"Jpn. J. Sarcoidosis Granulomatous Disord."},{"issue":"7","key":"10.1016\/j.ijcard.2020.11.044_bb0015","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm."},{"issue":"4","key":"10.1016\/j.ijcard.2020.11.044_bb0020","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jacc.2016.03.605","article-title":"Cardiac Sarcoidosis","volume":"68","author":"Birnie","year":"2016","journal-title":"JACC."},{"issue":"20","key":"10.1016\/j.ijcard.2020.11.044_bb0025","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1161\/CIRCULATIONAHA.109.851352","article-title":"Detection of myocardial damage in patients with sarcoidosis","volume":"120","author":"Patel","year":"2009","journal-title":"Circulation."},{"issue":"4","key":"10.1016\/j.ijcard.2020.11.044_bb0030","first-page":"325","article-title":"Cardiovascular magnetic resonance-guided diagnosis of cardiac affection in a Caucasian sarcoidosis population","volume":"32","author":"Pizarro","year":"2016","journal-title":"Sarcoidosis Vasculitis Diffuse Lung Dis."},{"issue":"4","key":"10.1016\/j.ijcard.2020.11.044_bb0035","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1378\/chest.14-0139","article-title":"Incidence and prognostic significance of myocardial late gadolinium enhancement in patients with sarcoidosis without cardiac manifestation","volume":"146","author":"Nagai","year":"2014","journal-title":"Chest."},{"issue":"9","key":"10.1016\/j.ijcard.2020.11.044_bb0040","first-page":"1522","article-title":"Inflammation and infection: imaging properties of 18F-FDG-labeled white blood cells versus 18F-FDG","volume":"46","author":"Pellegrino","year":"2005","journal-title":"J. Nuclear Med."},{"key":"10.1016\/j.ijcard.2020.11.044_bb0045","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.ijcard.2016.07.233","article-title":"High mass (>18g) of late gadolinium enhancement on CMR imaging is associated with major cardiac events on long-term outcome in patients with biopsy-proven extracardiac sarcoidosis","volume":"222","author":"Agoston-Coldea","year":"2016","journal-title":"Int. J. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcard.2020.11.044_bb0050","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jcmg.2012.10.021","article-title":"CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis","volume":"6","author":"Greulich","year":"2013","journal-title":"J. Am. Coll. Cardiol. Img."},{"key":"10.1016\/j.ijcard.2020.11.044_bb0055","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","year":"2019"},{"issue":"2","key":"10.1016\/j.ijcard.2020.11.044_bb0060","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.amjcard.2005.03.059","article-title":"Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis","volume":"96","author":"Aizer","year":"2005","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2020.11.044_bb0065","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ijcard.2018.11.131","article-title":"Treatment of cardiac sarcoidosis: A comparative study of steroids and steroids plus immunosuppressive drugs","volume":"276","author":"Ballul","year":"2019","journal-title":"Int. J. Cardiol."},{"issue":"6","key":"10.1016\/j.ijcard.2020.11.044_bb0070","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.hrthm.2012.02.010","article-title":"Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators","volume":"9","author":"Betensky","year":"2012","journal-title":"Heart Rhythm."},{"issue":"9","key":"10.1016\/j.ijcard.2020.11.044_bb0075","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.amjcard.2014.01.434","article-title":"Cardiac sarcoidosis detected by late gadolinium enhancement and prevalence of atrial arrhythmias","volume":"113","author":"Cain","year":"2014","journal-title":"Am. J. Cardiol."},{"issue":"6","key":"10.1016\/j.ijcard.2020.11.044_bb0080","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1161\/CIRCEP.113.000156","article-title":"Magnetic resonance imaging for identifying patients with cardiac sarcoidosis and preserved or mildly reduced left ventricular function at risk of ventricular arrhythmias","volume":"7","author":"Crawford","year":"2014","journal-title":"Circ. Arrhythm. Electrophysiol."},{"issue":"5","key":"10.1016\/j.ijcard.2020.11.044_bb0085","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.003040","article-title":"Magnetic resonance imaging as a predictor of survival free of life-threatening arrhythmias and transplantation in cardiac sarcoidosis","volume":"5","author":"Ekstrom","year":"2016","journal-title":"J. Am. Heart Assoc."},{"issue":"4","key":"10.1016\/j.ijcard.2020.11.044_bb0090","article-title":"Clinical presentation, management and prognosis of patients with cardiac sarcoidosis","volume":"65","author":"Ghanizada","year":"2018","journal-title":"Danish Med. J."},{"issue":"4","key":"10.1016\/j.ijcard.2020.11.044_bb0095","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jcmg.2012.10.021","article-title":"CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis","volume":"6","author":"Greulich","year":"2013","journal-title":"JACC Cardiovasc. Imaging"},{"issue":"7","key":"10.1016\/j.ijcard.2020.11.044_bb0100","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","article-title":"Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study","volume":"131","author":"Kandolin","year":"2015","journal-title":"Circulation."},{"issue":"1","key":"10.1016\/j.ijcard.2020.11.044_bb0105","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10840-015-9978-3","article-title":"Outcomes of patients with definite and suspected isolated cardiac sarcoidosis treated with an implantable cardiac defibrillator","volume":"43","author":"Kron","year":"2015","journal-title":"J. Interven. Cardiac Electrophysiol."},{"issue":"2","key":"10.1016\/j.ijcard.2020.11.044_bb0110","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/jce.12302","article-title":"Cardiac sarcoidosis: electrophysiological outcomes on long-term follow-up and the role of the implantable cardioverter-defibrillator","volume":"25","author":"Mohsen","year":"2014","journal-title":"J. Cardiovasc. Electrophysiol."},{"issue":"3","key":"10.1016\/j.ijcard.2020.11.044_bb0115","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1161\/CIRCEP.113.000734","article-title":"Systematic treatment approach to ventricular tachycardia in cardiac sarcoidosis","volume":"7","author":"Naruse","year":"2014","journal-title":"Circ. Arrhythm. Electrophysiol."},{"issue":"8","key":"10.1016\/j.ijcard.2020.11.044_bb0120","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.117.006145","article-title":"Outcome of cardiac Sarcoidosis presenting with high-grade Atrioventricular block","volume":"11","author":"Nordenswan","year":"2018","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"10.1016\/j.ijcard.2020.11.044_bb0125","article-title":"Electrophysiology study for risk stratification in patients with cardiac sarcoidosis and abnormal cardiac imaging","volume":"23","author":"Okada","year":"2019","journal-title":"IJC Heart Vasc."},{"issue":"9","key":"10.1016\/j.ijcard.2020.11.044_bb0130","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1540-8167.2012.02350.x","article-title":"Implantable cardioverter defibrillator therapy in patients with cardiac sarcoidosis","volume":"23","author":"Schuller","year":"2012","journal-title":"J. Cardiovasc. Electrophysiol."},{"issue":"6","key":"10.1016\/j.ijcard.2020.11.044_bb0135","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/europace\/eun110","article-title":"Ventricular tachyarrhythmia as a primary presentation of sarcoidosis","volume":"10","author":"Uusimaa","year":"2008","journal-title":"Europace."},{"issue":"10","key":"10.1016\/j.ijcard.2020.11.044_bb0140","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1111\/jce.14058","article-title":"Electrophysiologic testing for diagnostic evaluation and risk stratification in patients with suspected cardiac sarcoidosis with preserved left and right ventricular systolic function","volume":"30","author":"Zipse","year":"2019","journal-title":"J. Cardiovasc. Electrophysiol."},{"issue":"4","key":"10.1016\/j.ijcard.2020.11.044_bb0145","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/0735-1097(91)90750-4","article-title":"Sustained ventricular tachycardia associated with sarcoidosis: assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy, and implantable antitachycardia device","volume":"18","author":"Winters","year":"1991","journal-title":"JACC"},{"issue":"1","key":"10.1016\/j.ijcard.2020.11.044_bb0150","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jjcc.2019.04.016","article-title":"Prognosis and risk stratification in cardiac sarcoidosis patients with preserved left ventricular ejection fraction","volume":"75","author":"Chiba","year":"2020","journal-title":"J. Cardiol."},{"key":"10.1016\/j.ijcard.2020.11.044_bb0155","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ijcard.2017.03.033","article-title":"Risk assessment of patients with clinical manifestations of cardiac sarcoidosis with positron emission tomography and magnetic resonance imaging","volume":"241","author":"Bravo","year":"2017","journal-title":"Int. J. Cardiol."},{"issue":"15","key":"10.1016\/j.ijcard.2020.11.044_bb0160","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/heartjnl-2013-305187","article-title":"Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis","volume":"100","author":"Ise","year":"2014","journal-title":"Heart."},{"issue":"1","key":"10.1016\/j.ijcard.2020.11.044_bb0165","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.115.003738","article-title":"Prognosis of myocardial damage in sarcoidosis patients with preserved left ventricular ejection fraction: risk stratification using cardiovascular magnetic resonance","volume":"9","author":"Murtagh","year":"2016","journal-title":"Circ. Cardiovasc. imag."},{"issue":"1","key":"10.1016\/j.ijcard.2020.11.044_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.crad.2018.09.015","article-title":"Evaluation of FDG PET combined with cardiac MRI for the diagnosis and therapeutic monitoring of cardiac sarcoidosis","volume":"74","author":"Sgard","year":"2019","journal-title":"Clin. Radiol."},{"issue":"7","key":"10.1016\/j.ijcard.2020.11.044_bb0175","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/ehjci\/jex340","article-title":"Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography\/magnetic resonance imaging in cardiac sarcoidosis","volume":"19","author":"Wicks","year":"2018","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"issue":"12","key":"10.1016\/j.ijcard.2020.11.044_bb0180","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.jcmg.2016.11.019","article-title":"Complementary role of CMR to conventional screening in the diagnosis and prognosis of cardiac sarcoidosis","volume":"10","author":"Kouranos","year":"2017","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.ijcard.2020.11.044_bb0185","article-title":"FDG-PET in possible cardiac sarcoidosis: right ventricular uptake and high total cardiac metabolic activity predict cardiovascular events","author":"Tuominen","year":"2019","journal-title":"J. Nucl. Cardiol."},{"key":"10.1016\/j.ijcard.2020.11.044_bb0190","first-page":"988","article-title":"Right ventricular involvement is an important prognostic factor and risk stratification tool in suspected cardiac sarcoidosis: analysis by cardiac magnetic resonance imaging","volume":"109","author":"Kagloka","year":"2019","journal-title":"Clin. Res. Cardiol."},{"issue":"6","key":"10.1016\/j.ijcard.2020.11.044_bb0195","first-page":"448","article-title":"Delayed enhancement on cardiac magnetic resonance imaging is a poor prognostic factor in patients with cardiac sarcoidosis","volume":"60","author":"Shafee","year":"2012"},{"issue":"5","key":"10.1016\/j.ijcard.2020.11.044_bb0200","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s12350-014-9901-9","article-title":"Quantitative interpretation of FDG PET\/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis","volume":"21","author":"Ahmadian","year":"2014","journal-title":"J. Nucl. Cardiol."},{"key":"10.1016\/j.ijcard.2020.11.044_bb0205","article-title":"Prognostic value of phase analysis on gated single photon emission computed tomography in patients with cardiac sarcoidosis","author":"Koyanagawa","year":"2019","journal-title":"J. Nuclear Cardiol."},{"issue":"10","key":"10.1016\/j.ijcard.2020.11.044_bb0210","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.amjcard.2017.02.010","article-title":"Incremental prognostic value of global longitudinal strain and 18F-Fludeoxyglucose positron emission tomography in patients with systemic Sarcoidosis","volume":"119","author":"Sperry","year":"2017","journal-title":"Am. J. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcard.2020.11.044_bb0215","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/CIRCEP.110.958322","article-title":"Primary prevention of sudden cardiac death in silent cardiac sarcoidosis: role of programmed ventricular stimulation","volume":"4","author":"Mehta","year":"2011","journal-title":"Circ. Arrhythm. Electrophysiol."},{"issue":"21","key":"10.1016\/j.ijcard.2020.11.044_bb0225","article-title":"Delayed enhancement on cardiac magnetic resonance imaging is a poor prognostic factor in patients with cardiac sarcoidosis","volume":"126","author":"Abdel-Shafee","year":"2012","journal-title":"Circulation."},{"issue":"39","key":"10.1016\/j.ijcard.2020.11.044_bb0235","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Authors\/Task Force m","year":"2014","journal-title":"Eur. Heart J."},{"issue":"10","key":"10.1016\/j.ijcard.2020.11.044_bb0240","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1016\/j.hrthm.2017.10.035","volume":"15","author":"Al-Khatib","year":"2018","journal-title":"Heart Rhythm."},{"issue":"6","key":"10.1016\/j.ijcard.2020.11.044_bb0245","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1136\/heartjnl-2015-308708","article-title":"Consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"102","author":"Birnie","year":"2016","journal-title":"Heart."},{"issue":"1","key":"10.1016\/j.ijcard.2020.11.044_bb0250","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.amjcard.2004.08.083","article-title":"Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis","volume":"95","author":"Chiu","year":"2005","journal-title":"Am. J. Cardiol."},{"issue":"9","key":"10.1016\/j.ijcard.2020.11.044_bb0255","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0002-9149(01)01978-6","article-title":"Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone","volume":"88","author":"Yazaki","year":"2001","journal-title":"Am. J. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcard.2020.11.044_bb0260","first-page":"151","article-title":"Value of MRI for the diagnosis of cardiac involvement in sarcoidosis","volume":"24","author":"Dhote","year":"2003","journal-title":"Rev. Med. Interne"},{"issue":"6","key":"10.1016\/j.ijcard.2020.11.044_bb0265","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1378\/chest.07-2784","article-title":"Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing","volume":"133","author":"Mehta","year":"2008","journal-title":"Chest."},{"issue":"9","key":"10.1016\/j.ijcard.2020.11.044_bb0270","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1046\/j.1540-8167.2003.01554.x","article-title":"Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics versus implantable defibrillators (AVID) trial","volume":"14","author":"Klein","year":"2003","journal-title":"J. Cardiovasc. Electrophysiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752732034167X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752732034167X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:51:25Z","timestamp":1759092685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016752732034167X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":52,"alternative-id":["S016752732034167X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2020.11.044","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk and predictors of sudden death in cardiac sarcoidosis: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2020.11.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}